Steven Cohen's EVMN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.44 M shares of Evommune, Inc. (EVMN) worth $19.07 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in EVMN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 1.4 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Evommune (EVMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evommune (EVMN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.4 M | Add 3823.36% | 1.44 M | $13.29 |
| Q1 2026 | +2,193 | Add 6.38% | 36,577 | $22.99 |
| Q4 2025 | +34,384 | New Buy | 34,384 | $17.12 |
Steven Cohen's Evommune Investment FAQs
Steven Cohen first purchased Evommune, Inc. (EVMN) in Q4 2025, acquiring 34,384 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Evommune, Inc. (EVMN) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Evommune, Inc. (EVMN) was in Q2 2026, adding 1,435,049 shares worth $19.07 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,435,049 shares of Evommune, Inc. (EVMN), valued at approximately $19.07 M.
As of the Q2 2026 filing, Evommune, Inc. (EVMN) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Evommune, Inc. (EVMN) was 1,435,049 shares, as reported at the end of Q2 2026.